Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Pediatr Blood Cancer. 2010 Aug 25;55(7):1329–1337. doi: 10.1002/pbc.22710

Figure 2.

Figure 2

Plots depicting tumor growth and survival of mice treated with GSK960693 versus controls. Median tumor volume over time (left) and Kaplan-Meier plot of EFS over time (right) for the xenografts OS-33 (A) and KT-12 (B). Gray lines indicate vehicle-treated control mice and black lines indicate GSK690693-treated mice.